• TG003: A Selective Clk Family Kinase Inhibitor for Advanc...

  2025-10-22

  TG003 empowers researchers with precise, reversible control over alternative splicing and Clk-mediated phosphorylation, making it indispensable for investigating platinum resistance and developing exon-skipping therapies. Its robust selectivity for Clk kinases enables innovative workflows across cancer, RNA biology, and neuromuscular models.

• TG003: Expanding the Frontiers of Clk Kinase Inhibition i...

  2025-10-21

  Explore the advanced mechanisms and translational potential of TG003, a potent Cdc2-like kinase inhibitor, in alternative splicing modulation and platinum-resistant cancer research. This in-depth analysis reveals novel insights and future directions in Clk-mediated pathway targeting.

242 records 17/17 page Previous First page 上5页 1617